Physician profile
Lawrence Yu
NPI 1861873861
$680.37
in general payments reported to CMS, 2019-2025
11 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2.98 · 2020: $33.02 · 2021: $50.37 · 2022: $34.64 · 2023: $224 · 2024: $140 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527 · Honoraria: $32.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.55 |
| Honoraria | $32.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $146.82 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sight Sciences, INC. | $146.07 | 2023 | Tearcare System |
| Alcon Vision LLC | $139.16 | 2020-2024 | Rocklatan |
| Bausch & Lomb Americas INC. | $82.85 | 2025 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $38.57 | 2023 | Cequa |
| Dompe US, INC. | $31.06 | 2024 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $27.27 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $26.70 | 2024 | Tyrvaya |
| Thea Pharma INC. | $21.65 | 2023 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Abb Con-Cise Optical Group LLC | $2.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.